• The Ticker
  • Message Boards
  • Jobs
  • Medtech[y] Shop
  • 
  • 
  • 
  • View
  • ALL
  • Biotech
  • Medical Device
  • Robotic Surgery
  • Medical Device Sales
  • Medtechy Deals
  • Future of Healthcare
  • Healthcare Fraud
  • Hospitals

Join Our Mailing List Today

Sorrento Announces the Submission of a Marketing Authorization Application to COFEPRIS (Mexico) for COVI-STIX™ Rapid Detection Test of SARS-CoV-2 Viral Antigen

Posted in Biotech

December 30, 2020 • 2 min read

SAN DIEGO, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that a Marketing Authorization Application has been submitted by its agents in Mexico to Comisión Federal para la Protección...

Vertex Announces New Drug Submission for Investigational Triple Combination Medicine for the Treatment of Cystic Fibrosis Has Been Accepted for Priority Review by Health Canada

Posted in Biotech

December 28, 2020 • 2 min read

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced its New Drug Submission for TRIKAFTA®, Vertex’s investigational triple combination medicine, has been accepted...

Predictive Oncology’s TumorGenesis Division Secures First Commercial Sale of its Novel Ovarian Cancer Cell Media

Posted in Biotech

June 18, 2020 • 2 min read

MINNEAPOLIS, June 18, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive” or “the Company”) a knowledge-driven company focused on applying artificial intelligence to personalized medicine and drug discovery, today announces...

Catalyst Biosciences Announces Proposed Public Offering of Common Stock

Posted in Biotech

June 17, 2020 • 2 min read

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage biopharmaceutical company developing novel treatments for hemophilia and other rare bleeding disorders...

Outlook Therapeutics Provides Clinical Update on ONS-5010 / LYTENAVA (bevacizumab-vikg)

Posted in Biotech

June 17, 2020 • 2 min read

MONMOUTH JUNCTION, N.J., June 17, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the Company), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for us...

Sarepta Therapeutics Announces Positive Safety and Efficacy Data from the SRP-9001 Micro-Dystrophin Gene Therapy Trial Published in JAMA Neurology

Posted in Biotech

June 15, 2020 • 2 min read

CAMBRIDGE, Mass., June 15, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced safety and tolerability data at one year from four Duchenne muscular dystrophy (...

ACADIA Pharmaceuticals Submits Supplemental New Drug Application to U.S. FDA for NUPLAZID (pimavanserin) for the Treatment of Hallucinations and Delusions Associated with Dementia-Related Psychosis

Posted in Biotech

June 15, 2020 • 2 min read

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that the company submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to support a potential new indication for NUPL...

Dr. Reddy's Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir

Posted in Biotech

June 13, 2020 • 2 min read

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced that it has entered into a non-exclusive Lice...

INmune Bio, Inc. Receives Regulatory Approval from UK MHRA to Initiate Phase I Trial of INKmune in Patients with High-risk MDS

Posted in Biotech

June 11, 2020 • 2 min read

LA JOLLA, Calif., June 11, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announced that...

Advaxis Reports Second Quarter Ended April 30, 2020 Financial Results and Provides a Business Update

Posted in Biotech

June 11, 2020 • 2 min read

PRINCETON, N.J., June 11, 2020 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced an update on its clinical pipeline and ...

SUBMIT A TIP

Are you aware of fraud occurring at your workplace or previous place of employment?

Speak up, speak out, do the right thing.

REPORT HEALTHCARE FRAUD

TOP BOARD THREADS
  • Amarin EVAPORATE Study Results
    Amarin Message Board board
  • How do I get into Medical Device Sales?
    Medical Sales General Discussion board
  • What are the Best Biotech Stocks?
    Pharma/Biotech General Discussion board
  • FiercePharma's Top Pharma Companies in the World
    Pharma/Biotech Message Board board
  • Baker Brothers Advisors
    Pharma/Biotech General Discussion board
  • Will the FDA Approval Expanded Label for Vascepa?
    Amarin Message Board board
  • Is Amgen Looking to Acquire MannKind
    MannKind Message Board board
  • MedReps.com Jobs
    Medical Sales General Discussion board
  • Zimmer Biomet Layoffs
    Zimmer Biomet Message Board board
  • Medical Device Reps Back in the OR after COVID-19
    Medical Device Sales General Discussion board
  • READ MORE ON THE BOARDS

FEATURED JOBS
  • Medical Affairs Program Specialist
  • VIEW MORE JOBS

  • First Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page
  • Last Page

Developed by medical sales professionals for medical sales professionals.

 •  @medtechy •  medtechy

copyright Medtechy Inc. ⋅ Report A Tip ⋅ Terms of Use ⋅ Privacy Policy ⋅ DMCA Policy ⋅ Removal Policy ⋅ info@medtechy.com